SIGRID Stabiliser – Record online sales at Kronans Apotek lead to store launch this fall

Stockholm, August 27, 2025. After an exceptionally successful online launch earlier this year, Sigrid Therapeutics and Kronans Apotek are now ready to take the next step: SIGRID Stabiliser will be launched on store shelves across the country in the fall of 2025.

The launch of SIGRID Stabiliser on Sigrid's own e-commerce platform resulted in the stock being emptied within months. Now Sweden's largest pharmacy chain Kronans Apotek reports that since the product was launched in their e-commerce in February, demand has continued to exceed all expectations.

The product has sold out on several occasions and during campaign periods it has been the most requested product in three segments - Trend, Self-Care and Campaign. The interest has been so great that customers have actively searched for it in physical stores - which in turn has led to pharmacists requesting to have the product in the physical range.

The strong consumer response has led Kronans to now prepare a comprehensive launch in up to 100 physical pharmacies from autumn 2025, with a particular focus on stores in all major Swedish cities. SIGRID Stabiliser will also continue to be available via Kronans Apotek's own e-commerce, to ensure that all customers – regardless of where in the country they live – can easily order and access the product.

"We are incredibly proud to see SIGRID Stabiliser helping people take control of their health – without prescriptions, side effects or sacrifices," says Kasper Wickzén, Chief Commercial Officer at Sigrid Therapeutics . "Our brand is about living life to the fullest. SIGRID Stabiliser fits easily into your daily routine – no dietary changes are needed. By optimizing how your body digests food, you feel more energetic and in control throughout the day."

Jörgen Bitzekis, E-commerce Director at Kronans Apotek, adds:

"SIGRID Stabiliser has been an immediate hit with our online customers – a very successful launch. We quickly saw that demand was far above expectations – not least during promotions – and we are happy to be able to respond to that interest with wider availability in stores this autumn."

Cutting-edge technology – with strong results

SIGRID Stabiliser is based on the award-winning and patented SiPore® technology, initially developed at Professor Tore Bengtsson's laboratory at Stockholm University. SiPore® acts locally in the intestine by slowing the breakdown of carbohydrates, which leads to more stable blood sugar, reduced sugar cravings and a better feeling of satiety - without affecting the rest of the body.

Clinical studies and user surveys show strong results:

• 93% experience increased satiety
• 89% report reduced sugar cravings
• 92% feel less bloating

For more information, please contact:
Kasper Wickzén, Chief Commercial Officer, Sigrid Therapeutics